Related Experiment Video
Updated: Mar 8, 2026

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
Published on: August 20, 2016
Deptor: not only a mTOR inhibitor
Valeria Catena1, Maurizio Fanciulli2
1SAFU, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, Regina Elena National Cancer Institute, 00144, Rome, Italy. valeria.catena@ifo.gov.it.
Abstract:
Deptor is an important protein that belongs to the mTORC1 and mTORC2 complexes, able to interact with mTOR and to inhibit its kinase activity. As a natural mTOR inhibitor, Deptor is involved in several molecular pathways, such as cell growth, apoptosis, autophagy and ER stress response. For this reason, Deptor seems to play an important role in controlling cellular homeostasis. Despite several recent insights characterizing Deptor functions and regulation, its complete role within cells has not yet been completely clarified. Indeed, quite recently, Deptor has been associated with chromatin, and it has been demonstrated having a role in transcriptional regulation, controlling in such way endoplasmatic reticulum activity.From all these observations it is not surprising that Deptor can behave either as an oncogene or oncosuppressor, depending on the cell- or tissue-contexts. This review highlights recent progresses made in our understanding of the many activities of Deptor, describing its transcriptional and post-transcriptional regulation in different cancer cell types. Moreover, here we discuss the possibility of using compounds able to inhibit Deptor or to disrupt its interaction with mTOR as novel approaches for cancer therapy.
Insights
Deptor protein regulates cell growth and homeostasis by inhibiting mTOR kinase activity. Its dual role as an oncogene or oncosuppressor in cancer highlights its complex functions and therapeutic potential.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Deptor is a protein that inhibits the kinase activity of mTORC1 and mTORC2 complexes.
- It plays a role in cell growth, apoptosis, autophagy, and ER stress response, maintaining cellular homeostasis.
- Recent findings link Deptor to chromatin and transcriptional regulation, impacting endoplasmic reticulum activity.
Purpose of the Study:
- To review recent advancements in understanding Deptor's functions and regulation.
- To explore Deptor's dual role as an oncogene or oncosuppressor in various cellular contexts.
- To discuss therapeutic strategies targeting Deptor or its interaction with mTOR for cancer treatment.
Main Methods:
- Literature review of Deptor's transcriptional and post-transcriptional regulation.
- Analysis of Deptor's involvement in different cancer cell types.
- Discussion of potential therapeutic compounds targeting Deptor-mTOR interactions.
Main Results:
- Deptor's multifaceted roles in cellular processes are increasingly recognized.
- Deptor's function can be context-dependent, acting as either an oncogene or oncosuppressor.
- Understanding Deptor's regulation is crucial for deciphering its role in cancer.
Conclusions:
- Deptor is a key regulator of cellular homeostasis with implications in cancer.
- Targeting Deptor or its interaction with mTOR presents a promising avenue for novel cancer therapies.
- Further research is needed to fully elucidate Deptor's complex roles and therapeutic potential.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
05:28A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Drugs that Stabilize Microtubules
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...